146 related articles for article (PubMed ID: 19901127)
21. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
[TBL] [Abstract][Full Text] [Related]
22. [Serum carcinoembryonic antigen and beta-2-microglobulin studies in patients with cancer of the colon].
Schmidt I; Lörinczy E; Simon L
Orv Hetil; 1984 Sep; 125(39):2355-9. PubMed ID: 6384888
[No Abstract] [Full Text] [Related]
23. Carcinoembryonic antigen (CEA). A prospective clinical trail in patients with gastrointestinal cancer.
Kjaer M; Fischerman K
Scand J Gastroenterol Suppl; 1976; 37():99-106. PubMed ID: 1064149
[TBL] [Abstract][Full Text] [Related]
24. Value of a routine follow-up endoscopy program for the detection of recurrent colorectal carcinoma.
Barkin JS; Cohen ME; Flaxman M; Lindblad AS; Mayer RJ; Kalser MH; Steinberg SM
Am J Gastroenterol; 1988 Dec; 83(12):1355-60. PubMed ID: 3195539
[TBL] [Abstract][Full Text] [Related]
25. CEA as a prognostic factor in colorectal cancer.
Filella X; Molina R; Piqué JM; Grau JJ; Garcia-Valdecasas JC; Biete A; Novell F; Astudillo E; Bordas JM; Campo E
Anticancer Res; 1994; 14(2B):705-8. PubMed ID: 8010730
[TBL] [Abstract][Full Text] [Related]
26. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer.
Carpelan-Holmström MA; Haglund CH; Järvinen HJ; Roberts PJ
Anticancer Res; 1996; 16(2):981-6. PubMed ID: 8687164
[TBL] [Abstract][Full Text] [Related]
27. [The value of follow-up studies after surgery of carcinoma of the large intestine].
de Brauw LM; van de Velde CJ; Albers GH; Zwaveling A
Ned Tijdschr Geneeskd; 1987 Mar; 131(12):496-500. PubMed ID: 3574501
[No Abstract] [Full Text] [Related]
28. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
Yamamoto S; Akasu T; Fujita S; Moriya Y
Hepatogastroenterology; 2005; 52(62):444-9. PubMed ID: 15816454
[TBL] [Abstract][Full Text] [Related]
29. [Carcinoembryonic antigen in diagnosis and monitoring of colorectal cancer].
Forones NM; Tanaka M; Machado D; Falcão JB; Giovanoni M
Arq Gastroenterol; 1997; 34(1):3-6. PubMed ID: 9458953
[TBL] [Abstract][Full Text] [Related]
30. [Value of oncologic follow-up of patients operated for colorectal cancer. A prospective study of 1000 patients].
Arnaud JP; Cervi C; Bergamaschi R; Tuech JJ
J Chir (Paris); 1997 Jul; 134(2):45-50. PubMed ID: 9378783
[TBL] [Abstract][Full Text] [Related]
31. [Clinical manifestations and diagnosis of recurrent and metachronous cancer of the colon].
Prorokov VV; Anan'ev VS; Russu PM
Vopr Onkol; 1986; 32(10):79-82. PubMed ID: 3776131
[TBL] [Abstract][Full Text] [Related]
32. [Carcinoembryonal antigen and the follow up of patients after resection of colon carcinoma with curative intent: a Markov process in decision analysis].
Kievit J; van de Velde CJ; de Vries BC
Ned Tijdschr Geneeskd; 1989 Sep; 133(36):1784-9. PubMed ID: 2812076
[TBL] [Abstract][Full Text] [Related]
33. Preoperative investigations for metastatic staging of colon and rectal cancer across multiple centres--what is current practice?
Kosmider S; Stella DL; Field K; Moore M; Ananda S; Oakman C; Singh M; Gibbs P
Colorectal Dis; 2009 Jul; 11(6):592-600. PubMed ID: 18624816
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic criteria and risk groups in colorectal cancer].
Mentges B; Brückner R
Wien Med Wochenschr; 1988 Jul; 138(13):317-22. PubMed ID: 3188544
[TBL] [Abstract][Full Text] [Related]
35. [The function of the level of serum carcinoembryonic antigen on early recurrence of non-small cell lung cancer].
Zhang ZF; Ma JQ; Sun N; Zhang L
Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):817-9. PubMed ID: 15363304
[TBL] [Abstract][Full Text] [Related]
36. [Consensus follow-up study after surgery for colonic or rectal carcinoma].
Neijt JP; Welvaart K
Ned Tijdschr Geneeskd; 1988 Jul; 132(30):1400-3. PubMed ID: 3412513
[No Abstract] [Full Text] [Related]
37. [Clinical utility of tumor markers in gastric and colon cancer].
Ogawa K; Naritaka Y; Koyama N; Ohtani Y; Kawata H; Yagawa H; Kajiwara T; Sakakibara N
Gan No Rinsho; 1985 May; 31(6 Suppl):638-47. PubMed ID: 3861884
[TBL] [Abstract][Full Text] [Related]
38. [Significance of CEA and CA 19-9 for after care of curatively resected colorectal cancers].
Stapel A; Franke U; Putzki H
Zentralbl Chir; 1992; 117(2):77-80. PubMed ID: 1315472
[TBL] [Abstract][Full Text] [Related]
39. [Colorectal carcinoma. Diagnostic value of various biological markers in postoperative recurrences].
Antón Aranda E; Martí Cabané J; Tiberio López G; Pérez Garciá C
Rev Clin Esp; 1984 Jan; 172(2):69-73. PubMed ID: 6201959
[No Abstract] [Full Text] [Related]
40. Carcinoembryonic antigen in the diagnosis and follow-up of colorectal carcinoma.
Kåresen R; Hertzberg J; Johannesen J; Thoresen BO; Orjasaeter H
Am J Proctol Gastroenterol Colon Rectal Surg; 1980 Nov; 31(11):18-22. PubMed ID: 7212050
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
